Example: Heart Attack

Search clinical trials for: Modulation of FiO2

Total 10000 results

NCT04079231

Withdrawn

Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema (BUZZARD)

Diabetic Macula Edema
NCT02226289

Unknown

Bevacizumab-containing Regimen for Metastatic Colorectal Cancer Failed to Cytotoxic Treatment (BATTLE)

Colorectal Cancer | Neoplasm | Metastatic Neoplasm
NCT02800642

Completed

Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO (CENTERA)

Central Retinal Vein Occlusion
NCT04355273

Completed

Effects of Different Concentrations of Pressurized-heparin Flushing Fluid on Coagulation and Platelet Function Monitored by the Sonoclot Analyzer

Perioperative | Heparin
NCT03505502

Completed

Reducing Blood Loss During Cesarean Myomectomy With Tranexamic Acid (TA)

Cesarean Section Complications
NCT02314377

Completed

Bevacizumab Therapy for Brain Arteriovenous Malformation

Brain Arteriovenous Malformation
NCT00337207

Completed

Bevacizumab in Treating Patients With Recurrent or Progressive Glioma

Brain and Central Nervous System Tumors
NCT03246152

Completed

Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA (IMPACT)

Diabetic Macular Edema | Ischemic Maculopathy
NCT04224116

Completed

Tranexamic Acid Contribution in the Prevention of Perioperative Bleeding in Thoracic Surgery (Bleeding)

Bleeding
NCT04021173

Unknown

A Clinical Study of Anfibatide in Acquired Thrombotic Thrombocytopenic Purpura (TTP)

Acquired Thrombotic Thrombocytopenic Purpura
NCT01748292

Completed

Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab (T-REX)

Macular Degeneration
NCT03312283

Completed

Evaluating of the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet AMD

Wet Age-related Macular Degeneration
NCT02366468

Completed

Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema (DIVERSE)

Diabetic Retinopathy
NCT00041782

Terminated

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Neoplasms | Deep Vein Thrombosis
NCT03686787

Unknown

Oral Tranexamic Acid and Laser for Treatment of Melasma

Melasma
NCT02645747

Completed

Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion (RETRO CRVO)

Retinal Vein Occlusion
NCT00611559

Completed

Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis
NCT02319915

Completed

Evaluation of the Pharmacokinetic Profile of Tranexamic Acid, After Injection in a Knee Neo-articulation.

Knee Prosthesis
NCT00466895

Completed

Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.

Acute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia
NCT00981903

Terminated

Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer

Cancer | Venous Thromboembolism
NCT01710332

Completed

The Safety & Efficacy of Intravitreal Aflibercept Injection in Patients With Persistent Central Serous Chorioretinopathy (CONTAIN)

Central Serous Chorioretinopathy
NCT00445211

Terminated

HEROIC (Heparin Requirement in Counterpulsation) (HEROIC)

Cardiogenic Shock
NCT03060889

Completed

Tranexamic Acid Use in Elective Cesarean Section for Women With Placenta Previa

Placenta Previa
NCT01947309

Terminated

Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)

Multiple Myeloma
NCT00446433

Completed

A Study to Evaluate CC-5013 in the Treatment of Adolescents and Adults With Moderately Severe Crohn's Disease

Crohn's Disease
NCT02258009

Withdrawn

Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema (TIDE DME)

Visual Impairment Due to Diabetic Macular Edema
NCT00518102

Completed

The Risk of Cancer in Users of Regranex (Becaplermin) and Matched Comparators (Nonusers of Regranex [Becaplermin])

Diabetes Mellitus
NCT01363570

Completed

Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes

Age Related Macular Degeneration
NCT00504959

Completed

Safety and Tolerability of Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Subfoveal Choroidal Neovascularization (CNV) | Secondary to Age-related Macular Degeneration (AMD)
NCT00745498

Completed

Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy (IBDV)

Proliferative Diabetic Retinopathy | Vitreous Hemorrhage
NCT01683747

Terminated

Single Dose Enteral Tranexamic Acid in Critically Ill Patients

Sepsis | Shock | Critical Illness | Hypotension
NCT00271401

Completed

A Study Comparing the Efficacy and Safety of Intracoronary Stenting With or Without Abciximab, an Anti-Platelet Therapy, and Conventional Coronary Angioplasty With Abciximab

Angioplasty, Transluminal, Percutaneous Coronary
NCT00557791

Withdrawn

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD (CARBON) (CARBON)

Age Related Macular Degeneration
NCT01419977

Completed

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Sickle Cell Disease | Vaso-occlusive Crisis
NCT01334879

Completed

High Dose Intravitreal Ranibizumab for Recalcitrant Radiation Retinopathy

Radiation Retinopathy
NCT01171976

Completed

Efficacy and Safety of Ranibizumab in Two "Treat and Extend" Treatment Algorithms Versus Ranibizumab As Needed in Patients With Macular Edema and Visual Impairment Secondary to Diabetes Mellitus (RETAIN)

Diabetic Macular Edema
NCT00754650

Completed

A Proof of Concept Study of the Safety, Tolerability, and Efficacy of Avastin (Bevacizumab) in Patients With Chemo-naive Chronic Lymphocytic Leukemia

Lymphocytic Leukemia, Chronic
NCT02173873

Unknown

Ziv-aflibercept in Eyes With Retinal Diseases and Poor Vision-phase I (ZIV)

Central Retinal Vein Occlusion | Age Related Macular Degeneration
NCT01277302

Completed

A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

Macular Edema
NCT02094066

Unknown

The Effect of Tranexamic Acid for Total Hip Arthroplasty

Hemorrhage
NCT00022048

Completed

Bevacizumab in Treating Patients With Myelodysplastic Syndrome

Myelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative Neoplasms
NCT01744756

Completed

Subconjunctival Bevacizumab and Recurrent Pterygium (BRP)

Recurrent Pterygium
NCT01218594

Unknown

Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer (DP-EN-RT)

Non-small Cell Lung Cancer
NCT00005061

Completed

Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific
NCT00510965

Completed

Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)

Choroidal Neovascularization
NCT01015300

Terminated

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Von Hippel Lindau Disease | Hemangioblastomas
NCT00761449

Completed

Lenalidomide in High-risk MDS and AML With Del(5q) or Monosomy 5

AML | MDS
NCT01111669

Completed

Intravenous Tranexamic Acid and Intraoperative Visualization During Functional Endoscopic Sinus Surgery

Chronic Rhinosinusitis With Polyposis | Chronic Hyperplastic Sinusitis
NCT01442064

Completed

An Extension Study to Evaluate Safety and Tolerability of Ranibizumab in Macular Edema Secondary to Retinal Vein Occlusion (Cohort 2)

Macular Edema | Retinal Vein Occlusion
NCT00735280

Completed

Reduced Dose of Unfractionated Heparin in Patients Undergoing PCI (ISAR-REACT-3A)

Coronary Artery Disease

Search clinical trials for: Modulation of FiO2

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations